Advanced Accelerator Applications (English Wikipedia)
Analysis of information sources in references of the Wikipedia article "Advanced Accelerator Applications" in English language version.
refsWebsite
Global rank
English rank
1st place
1st place
2,093rd place
1,184th place
low place
low place
7th place
7th place
1,684th place
1,350th place
low place
low place
1,027th place
3,300th place
49th place
47th place
1,287th place
5,624th place
5th place
5th place
low place
6,625th place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
low place
8,069th place
7,681st place
low place
low place
low place
low place
adacap.com
- "Advanced Accelerator Applications Nuclear Medicine Glossary". Archived from the original on 2015-04-13. Retrieved 2015-04-15.
adnkronos.com
cancer.gov
- "FDA Approves New Treatment for Neuroendocrine Tumors". National Cancer Institute. 8 February 2018. Retrieved 2018-05-26.
- "NCI Drug Dictionary". National Cancer Institute. Retrieved 2018-05-26.
devicespace.com
europa.eu
ema.europa.eu
- "LysaKare EPAR". European Medicines Agency (EMA). 26 August 2024. Retrieved 26 August 2024.
This article incorporates text from this source, which is in the public domain.
fda.gov
- Commissioner, Office of the. "Press Announcements - FDA approves new treatment for certain digestive tract cancers". www.fda.gov. Archived from the original on January 28, 2018. Retrieved 2018-05-26.
ft.com
- "Siemens Healthineers boosts cancer imaging with €200mn Novartis deal". www.ft.com. Retrieved 2024-08-26.
genengnews.com
- Staff, G. E. N. (2024-01-24). "Novartis Automates New Radioligand Therapy Production Plant". GEN - Genetic Engineering and Biotechnology News. Retrieved 2024-08-26.
hemonc.org
- Warner, Jeremy L; Fitts, Austin; Warner, Jeremy (6 May 2021). "Lutetium Lu 177 dotatate (Lutathera)". HemOnc.org. Retrieved 14 August 2022.
lutathera.com
- "For Patients - Lutathera". Lutathera. Retrieved 2018-05-26.
medicaldevicedaily.com
- "Medicaldevicedaily.com, "AAA to increase clinical trials of MNM diagnostic products", Febr 19th, 2014" (PDF). Archived from the original (PDF) on 2014-04-08. Retrieved 2014-04-07.
news-medical.net
northjersey.com
archive.northjersey.com
- Danielle Desisto. "Millburn manufacturing site safely produces cancer-fighting drug".
- "Concerns raised about proposed cancer drug factory in Millburn"
theitem.northjersey.com
- Cecilia Levine. "Nuclear meds expert hired". The Record. 7 May 2015.
northjersey.com
- Harry Trumbore. "Expert says radiopharmaceutical factory proposed for Millburn is safe" . 11 February 2016
novartis.com
- "Novartis Completes Tender Offer for Advanced Accelerator Applications" (Press release). Novartis. 23 January 2018.
- "Novartis completes tender offer for Advanced Accelerator Applications S.A. and announces commencement of subsequent offering period". Novartis. Retrieved 2024-08-26.
- "Advanced Accelerator Applications Receives FDA Approval for Lutathera® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors | Novartis". Novartis. Retrieved 2018-05-26.
nytimes.com
- Larsen, Peter Thal (2017-10-30). "Novartis Makes a Deal That Should Go Down Easy". The New York Times. ISSN 0362-4331. Retrieved 2024-08-26.
- Larsen, Peter Thal (30 October 2017). "Novartis Makes a Deal That Should Go Down Easy". The New York Times.
pharmatimes.com
- Parsons, Lucy (2021-06-21). "Novartis' radioligand therapy granted US Breakthrough Therapy Designation". PharmaTimes Online. Retrieved 2021-07-10.
privateequitywire.co.uk
reuters.com
uk.reuters.com
- Miller, John (3 November 2017). "Novartis to buy French cancer specialist AAA for $3.9 billion". Reuters. Archived from the original on December 5, 2020.
tapinto.net
web.archive.org
- Miller, John (3 November 2017). "Novartis to buy French cancer specialist AAA for $3.9 billion". Reuters. Archived from the original on December 5, 2020.
- "Advanced Accelerator Applications Nuclear Medicine Glossary". Archived from the original on 2015-04-13. Retrieved 2015-04-15.
- "Medicaldevicedaily.com, "AAA to increase clinical trials of MNM diagnostic products", Febr 19th, 2014" (PDF). Archived from the original (PDF) on 2014-04-08. Retrieved 2014-04-07.
- Commissioner, Office of the. "Press Announcements - FDA approves new treatment for certain digestive tract cancers". www.fda.gov. Archived from the original on January 28, 2018. Retrieved 2018-05-26.
- Devicespace.com, "Advanced Accelerator Applications Receives Orphan Drug Designation From FDA And European Medicines Agency For Gallium-68 DOTATATE For Use In Patients With Gastro-Entero-Pancreatic Neuroendocrine Tumors" Archived 2014-04-08 at the Wayback Machine. 3 March 2014.
wiwo.de
- Wirtschaftswoche (30 October 2017). "Advanced Accelerator Applications: Novartis kauft Krebsspezialisten für 3,9 Milliarden Dollar". www.wiwo.de (in German). Retrieved 2022-08-20.
worldcat.org
search.worldcat.org
- Larsen, Peter Thal (2017-10-30). "Novartis Makes a Deal That Should Go Down Easy". The New York Times. ISSN 0362-4331. Retrieved 2024-08-26.